首页 | 本学科首页   官方微博 | 高级检索  
     

慢性荨麻疹与凝血机制的研究进展
引用本文:王朵勤,唐慧,徐金华. 慢性荨麻疹与凝血机制的研究进展[J]. 国际皮肤性病学杂志, 2011, 37(5). DOI: 10.3760/cma.j.issn.1673-4173.2011.05.014
作者姓名:王朵勤  唐慧  徐金华
作者单位:复旦大学附属华山医院皮肤科,上海,200040
摘    要:凝血机制在慢性荨麻疹的发病中起着重要的作用。内、外源性凝血途径同时被激活,产生凝血酶。凝血酶是一种蛋白酶激活受体激动剂,可诱导肥大细胞释放组胺,从而诱发荨麻疹的发生。其病情严重性随着凝血因子数量的增高而加重。抗凝药物及蛋白酶抑制剂对部分难治性荨麻疹有一定疗效。概述近几年针对凝血机制治疗慢性荨麻疹的研究进展。

关 键 词:荨麻疹  血液凝固  抗凝药  免疫抑制剂

Chronic urticaria and blood coagulation mechanism
WANG Duo-qin,TANG Hui,XU Jin-hua. Chronic urticaria and blood coagulation mechanism[J]. International Journal of Dermatology and Venereology, 2011, 37(5). DOI: 10.3760/cma.j.issn.1673-4173.2011.05.014
Authors:WANG Duo-qin  TANG Hui  XU Jin-hua
Abstract:Blood coagulation plays an important role in the pathogenesis of chronic urticaria. Both the intrinsic and extrinsic pathways of the coagulation cascade are activated in chronic urticaria, which in turn induce the generation of thrombin. Thrombin, as the agonist of proteinase-activated receptors, can induce histamine release from mast cells, and then cause the development of urticaria. The severity of urticaria is parallel to the quantity of coagulation factors. Anticoagulants and protease inhibitors have shown certain efficacy in the treatment of some refractory urticaria. This paper summarizes recent progress in the development of blood coagulation-targeting strategies for the treatment of chronic urticaria.
Keywords:Urticaria  Blood coagulation  Anticoagulants  Immunosuppressive agents
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号